BRIEF-KANGSTEM BIOTECH announces patent granted

* Says it receives a patent on July 18, for pharmaceutical

composition comprising stem cells treated with nod2 agonist or

culture thereof for prevention and treatment of immune disorders

and inflammatory diseases

Read more